Cargando…
Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application
INTRODUCTION: Lymph node status is a major prognostic factor in early-stage cervical cancer. Predicting the risk of lymph node metastasis is essential for optimal therapeutic management. The aim of the study was to develop a web-based application to predict the risk of lymph node metastasis in patie...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413841/ https://www.ncbi.nlm.nih.gov/pubmed/36033437 http://dx.doi.org/10.3389/fonc.2022.935628 |
_version_ | 1784775849815310336 |
---|---|
author | Guani, Benedetta Gaillard, Thomas Teo-Fortin, Ly-Ann Balaya, Vincent Feki, Anis Paoletti, Xavier Mathevet, Patrice Plante, Marie Lecuru, Fabrice |
author_facet | Guani, Benedetta Gaillard, Thomas Teo-Fortin, Ly-Ann Balaya, Vincent Feki, Anis Paoletti, Xavier Mathevet, Patrice Plante, Marie Lecuru, Fabrice |
author_sort | Guani, Benedetta |
collection | PubMed |
description | INTRODUCTION: Lymph node status is a major prognostic factor in early-stage cervical cancer. Predicting the risk of lymph node metastasis is essential for optimal therapeutic management. The aim of the study was to develop a web-based application to predict the risk of lymph node metastasis in patients with early-stage (IA1 with positive lymph vascular space invasion, IA2 and IB1) cervical cancer. MATERIALS AND METHODS: We performed a secondary analysis of data from two prospective multicenter trials, Senticol 1 and 2 pooled together in the training dataset. The histological risk factors were included in a multivariate logistic regression model in order to determine the most suitable prediction model. An internal validation of the chosen prediction model was then carried out by a cross validation of the ‘leave one out cross validation’ type. The prediction model was implemented in an interactive online application of the ‘Shinyapp’ type. Finally, an external validation was performed with a retrospective cohort from L’Hôtel-Dieu de Québec in Canada. RESULTS: Three hundred twenty-one patients participating in Senticol 1 and 2 were included in our training analysis. Among these patients, 280 did not present lymph node invasion (87.2%), 13 presented isolated tumor cells (4%), 11 presented micrometastases (3.4%) and 17 macrometastases (5.3%). Tumor size, presence of lymph-vascular space invasion and stromal invasion were included in the prediction model. The Receiver Operating Characteristic (ROC) Curve from this model had an area under the curve (AUC) of 0.79 (95% CI [0.69– 0.90]). The AUC from the cross validation was 0.65. The external validation on the Canadian cohort confirmed a good discrimination of the model with an AUC of 0.83. DISCUSSION: This is the first study of a prediction score for lymph node involvement in early-stage cervical cancer that includes internal and external validation. The web application is a simple, practical, and modern method of using this prediction score to assist in clinical management. |
format | Online Article Text |
id | pubmed-9413841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94138412022-08-27 Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application Guani, Benedetta Gaillard, Thomas Teo-Fortin, Ly-Ann Balaya, Vincent Feki, Anis Paoletti, Xavier Mathevet, Patrice Plante, Marie Lecuru, Fabrice Front Oncol Oncology INTRODUCTION: Lymph node status is a major prognostic factor in early-stage cervical cancer. Predicting the risk of lymph node metastasis is essential for optimal therapeutic management. The aim of the study was to develop a web-based application to predict the risk of lymph node metastasis in patients with early-stage (IA1 with positive lymph vascular space invasion, IA2 and IB1) cervical cancer. MATERIALS AND METHODS: We performed a secondary analysis of data from two prospective multicenter trials, Senticol 1 and 2 pooled together in the training dataset. The histological risk factors were included in a multivariate logistic regression model in order to determine the most suitable prediction model. An internal validation of the chosen prediction model was then carried out by a cross validation of the ‘leave one out cross validation’ type. The prediction model was implemented in an interactive online application of the ‘Shinyapp’ type. Finally, an external validation was performed with a retrospective cohort from L’Hôtel-Dieu de Québec in Canada. RESULTS: Three hundred twenty-one patients participating in Senticol 1 and 2 were included in our training analysis. Among these patients, 280 did not present lymph node invasion (87.2%), 13 presented isolated tumor cells (4%), 11 presented micrometastases (3.4%) and 17 macrometastases (5.3%). Tumor size, presence of lymph-vascular space invasion and stromal invasion were included in the prediction model. The Receiver Operating Characteristic (ROC) Curve from this model had an area under the curve (AUC) of 0.79 (95% CI [0.69– 0.90]). The AUC from the cross validation was 0.65. The external validation on the Canadian cohort confirmed a good discrimination of the model with an AUC of 0.83. DISCUSSION: This is the first study of a prediction score for lymph node involvement in early-stage cervical cancer that includes internal and external validation. The web application is a simple, practical, and modern method of using this prediction score to assist in clinical management. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9413841/ /pubmed/36033437 http://dx.doi.org/10.3389/fonc.2022.935628 Text en Copyright © 2022 Guani, Gaillard, Teo-Fortin, Balaya, Feki, Paoletti, Mathevet, Plante and Lecuru https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Guani, Benedetta Gaillard, Thomas Teo-Fortin, Ly-Ann Balaya, Vincent Feki, Anis Paoletti, Xavier Mathevet, Patrice Plante, Marie Lecuru, Fabrice Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application |
title | Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application |
title_full | Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application |
title_fullStr | Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application |
title_full_unstemmed | Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application |
title_short | Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application |
title_sort | estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: cervical cancer application |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413841/ https://www.ncbi.nlm.nih.gov/pubmed/36033437 http://dx.doi.org/10.3389/fonc.2022.935628 |
work_keys_str_mv | AT guanibenedetta estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT gaillardthomas estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT teofortinlyann estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT balayavincent estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT fekianis estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT paolettixavier estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT mathevetpatrice estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT plantemarie estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication AT lecurufabrice estimationriskoflymphnodalinvasioninpatientswithearlystagecervicalcancercervicalcancerapplication |